Clinical Laserthermia Systems AB (FRA:LS60) Short-Term Debt: €0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LS60 Clinical Laserthermia Systems AB FRA:LS60
42 GF Score
Price €0.24
GF Value €0.28
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Clinical Laserthermia Systems AB Short-Term Debt?

Clinical Laserthermia Systems AB FRA:LS60 +0.62% 42 Short-Term Debt is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:LS60 with a GF Score™ of 42/100 and a GF Value™ of €0.28 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Clinical Laserthermia Systems AB's Short-Term Debt for the quarter that ended in Mar. 2026 was €0.00 Mil.

Clinical Laserthermia Systems AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Clinical Laserthermia Systems AB Short-Term Debt Related Terms

Clinical Laserthermia Systems AB Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Clinical Laserthermia Systems AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinical Laserthermia Systems AB Short-Term Debt Chart

Clinical Laserthermia Systems AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 2.79 0.00 0.00 0.00

Clinical Laserthermia Systems AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:LS60
42GF Score
Clinical Laserthermia Systems AB FRA:LS60
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €0.00 Mil mean?
Clinical Laserthermia Systems AB (FRA:LS60) has a Short-Term Debt of €0.00 Mil as of Mar. 2026.
Is Clinical Laserthermia Systems AB's Short-Term Debt too high?
Clinical Laserthermia Systems AB's current Short-Term Debt is €0.00 Mil. Overall, Clinical Laserthermia Systems AB has a GF Score™ of 42/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clinical Laserthermia Systems AB's Short-Term Debt compare to ABT and SYK?
Clinical Laserthermia Systems AB's Short-Term Debt of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Clinical Laserthermia Systems AB's current Short-Term Debt is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinical Laserthermia Systems AB stock overvalued right now?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB (FRA:LS60) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.28, compared to a current price of €0.24 — trading 12.9% below its estimated fair value. The current Short-Term Debt is €0.00 Mil. Clinical Laserthermia Systems AB's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Clinical Laserthermia Systems AB (FRA:LS60), the current Short-Term Debt is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clinical Laserthermia Systems AB (FRA:LS60) Overvalued in 2026?

Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued. The current stock price of €0.24 is trading 12.9% below its estimated GF Value™ of €0.28. GuruFocus considers Clinical Laserthermia Systems AB to be Modestly Undervalued.

Key valuation signals for FRA:LS60:

  • Short-Term Debt: €0.00 Mil
  • GF Value™: €0.28 vs. price of €0.24 (12.9% below fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the FRA:LS60 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clinical Laserthermia Systems AB Business Description

Other Exchanges CLS B:Sweden
Address Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
42GF Score

Get the complete analysis for FRA:LS60

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.24
Price
€0.28
GF Value